Dr. Comander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
Boston, MA 02114Phone+1 617-573-3529
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2010 - 2012- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2007 - 2010
Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
MA State Medical License 2010 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Enhanced Career Development Award Foundation Fighting Blindness
- K12 Mentored Clinical Scientist Development Program Award NIH / National Eye Institute, 2012
- Career Development Award Research for Prevention of Blindness
Publications & Presentations
PubMed
- A comprehensive map of missense trafficking variants in rhodopsin and their response to pharmacologic correction.Kannan V Manian, Connor H Ludwig, Yan Zhao, Nathan Abell, Xiaoping Yang
Biorxiv. 2025-03-04 - Higher throughput assays for understanding the pathogenicity of variants of unknown significance (VUS) in the RPE65 gene.Leila Azizzadeh Pormehr, Kannan Vrindavan Manian, Ha Eun Cho, Jason Comander
Biorxiv. 2025-02-05 - Systematic empirical evaluation of individual base editing targets: Validating therapeutic targets in USH2A and comparison of methods.Yuki Tachida, Kannan V Manian, Rossano Butcher, Jonathan M Levy, Nachiket Pendse
Molecular Therapy. 2025-01-28
Journal Articles
- Moving Towards PDE6A Gene Supplementation TherapyJason Comander, MD, JAMA Ophthalmology
- Moving Towards PDE6A Gene Supplementation TherapyJason Comander, MD, JAMA Ophthalmology
Press Mentions
Clinical Challenges: Treating Leber Congenital AmaurosisNovember 29th, 2021
CRISPR Used Inside a Person’s Body for the First Time EverMarch 6th, 2020
CLINICAL TRIAL DOWNLOAD: Phase 1/2a Data on Human Retinal Progenitor Cell TherapyMarch 1st, 2020- Join now to see all
Grant Support
- Improving the throughput of diagnosis and treatment of inherited diseases of the retinaMASSACHUSETTS EYE AND EAR INFIRMARY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
